-
Entity Type
-
Individual
-
Role
-
COO, and President, Athenex Pharmaceutical Division.
-
Stock Symbol
-
ATNXQ
There are no Buy or Sell transactions made by Jeffrey Yordon since 11/21/2023
Holdings reported by Jeffrey Yordon for Athenex, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
246K |
$334K |
$1.36 |
Aug 3, 2022 |
Direct |
|
|
Stock Option (Right to Buy) |
150K |
|
|
Aug 3, 2022 |
Direct |
Common Stock |
150K |
Restricted Stock Units |
37.5K |
|
|
Aug 3, 2022 |
Direct |
Common Stock |
50K |
Transactions reported by Jeffrey Yordon for Athenex, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.